Back to search

Italy· 046084012

SALMETEROLO E FLUTICASONE SF

A salmeterol and fluticasone product containing salmeterolo/fluticasone, registered in Italy by S.F. GROUP S.R.L., on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC R03AK06

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedSALMETEROLO E FLUTICASONE SFATCR03AK06REGISTER NO.046084012PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Salmeterol and fluticasone is registered in 14 of 19 countries.

Countries holding a registration under ATC R03AK06 (salmeterol and fluticasone), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 9 of them publish a price we can compare per daily dose

Salmeterol and fluticasone · ATC R03AK06

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Salmeterolo/fluticasone
Manufacturer
S.F. GROUP S.R.L.
Country
Italy (IT)
ATC code
R03AK06
ATC class
Salmeterol and fluticasone
Defined daily dose
0.1 mg, Inhal
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    046084012
    "25 MICROGRAMMI/50 MICROGRAMMI/DOSE PREDOSATA SOSPENSIONE PRESSURIZZATA PER INALAZIONE" 1 INALATORE IN AL DA 120 DOSI
    EUR 26.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

718 interactions on record for salmeterol and fluticasone.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Salmeterol and fluticasone · interactions on record

718 records

  • 49 severe
  • 397 moderate
  • 24 minor
  • 248 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • PindololC07AA03severe
  • PropranololC07AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7fbbf2d-5e5c-48ab-a5cd-d07f181c6b2a
GET /v1/drugs/c7fbbf2d-5e5c-48ab-a5cd-d07f181c6b2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"25 MICROGRAMMI/50 MICROGRAMMI/DOSE PREDOSATA SOSPENSIONE PRESSURIZZATA PER INALAZIONE\" 1 INALATORE IN AL DA 120 DOSI",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Salmeterolo/fluticasone",
  "reference_pack": "120 DOSI 25 MCG+50 MCG - USO RESPIRATORIO",
  "public_price_eur": 26.2,
  "ssn_reference_price_eur": 26.2
}

See everything about salmeterol and fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.